171 related articles for article (PubMed ID: 35181243)
1. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.
Brugière O; Mouren D; Trichereau J; Vallée A; Kuzniak I; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Nieves A; Bunel V; Messika J; Demant X; Macey J; Le Pavec J; Dauriat G; Saint-Raymond C; Falque L; Mornex JF; Tissot A; Foureau A; Borgne Krams AL; Bousseau V; Magnan A; Picard C; Roux A; Carosella E; LeMaoult J; Rouas-Freiss N;
J Heart Lung Transplant; 2022 May; 41(5):626-640. PubMed ID: 35181243
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltrating and peripheral CD4
Jacquier A; Lambert T; Delattre JF; Djouadou M; Vérine J; Dumont C; Desgrandchamps F; Carosella ED; LeMaoult J; Rouas-Freiss N
Cancer Lett; 2021 Oct; 519():105-116. PubMed ID: 34186161
[TBL] [Abstract][Full Text] [Related]
3. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
4. CD8
Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
[TBL] [Abstract][Full Text] [Related]
5. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
6. Association of Higher CD4
Salman J; Ius F; Knoefel AK; Sommer W; Siemeni T; Kuehn C; Tudorache I; Avsar M; Nakagiri T; Preissler G; Hatz R; Greer M; Welte T; Haverich A; Warnecke G
Am J Transplant; 2017 Jun; 17(6):1637-1648. PubMed ID: 27931084
[TBL] [Abstract][Full Text] [Related]
7. Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.
Brugière O; Thabut G; Krawice-Radanne I; Rizzo R; Dauriat G; Danel C; Suberbielle C; Mal H; Stern M; Schilte C; Pretolani M; Carosella ED; Rouas-Freiss N
Am J Transplant; 2015 Feb; 15(2):461-71. PubMed ID: 25488753
[TBL] [Abstract][Full Text] [Related]
8. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
9. HLA-C mismatching improves outcomes following lung transplantation.
Hiho SJ; Levvey BJ; Diviney MB; Brooks AG; Holdsworth R; Snell GI; Westall GP; Sullivan LC
HLA; 2024 Jun; 103(6):e15544. PubMed ID: 38924641
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of CD4
Ius F; Salman J; Knoefel AK; Sommer W; Nakagiri T; Verboom M; Siemeni T; Poyanmehr R; Bobylev D; Kuehn C; Avsar M; Erdfelder C; Hallensleben M; Boethig D; Hecker H; Schwerk N; Mueller C; Welte T; Falk C; Preissler G; Haverich A; Tudorache I; Warnecke G
Transpl Int; 2020 May; 33(5):503-516. PubMed ID: 31903646
[TBL] [Abstract][Full Text] [Related]
11. Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.
Piloni D; Morosini M; Magni S; Balderacchi A; Scudeller L; Cova E; Oggionni T; Stella G; Tinelli C; Antonacci F; D'Armini AM; Meloni F
BMC Pulm Med; 2017 Jul; 17(1):102. PubMed ID: 28720146
[TBL] [Abstract][Full Text] [Related]
12. Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies.
Xu Q; Elrefaei M; Taupin JL; Hitchman KMK; Hiho S; Gareau AJ; Iasella CJ; Marrari M; Belousova N; Bettinotti M; Narula T; Alvarez F; Sanchez PG; Levvey B; Westall G; Snell G; Levine DJ; Zeevi A; Roux A
J Heart Lung Transplant; 2024 Apr; 43(4):663-672. PubMed ID: 38141896
[TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoints Expression in Chronic Lung Allograft Rejection.
Righi I; Vaira V; Morlacchi LC; Croci GA; Rossetti V; Blasi F; Ferrero S; Nosotti M; Rosso L; Clerici M
Front Immunol; 2021; 12():714132. PubMed ID: 34489963
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells in Lung Transplantation.
Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
Front Immunol; 2019; 10():900. PubMed ID: 31080450
[TBL] [Abstract][Full Text] [Related]
15. HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.
Di Cristofaro J; Reynaud-Gaubert M; Carlini F; Roubertoux P; Loundou A; Basire A; Frassati C; Thomas P; Gomez C; Picard C
Am J Transplant; 2015 Sep; 15(9):2413-20. PubMed ID: 25989360
[TBL] [Abstract][Full Text] [Related]
16. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
[TBL] [Abstract][Full Text] [Related]
17. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
[TBL] [Abstract][Full Text] [Related]
18. Phase-resolved Functional Lung (PREFUL) MRI-derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss.
Vogel-Claussen J; Kaireit TF; Voskrebenzev A; Klimeš F; Glandorf J; Behrendt L; Gutberlet M; Korz C; Speth M; Welte T; Wacker F; Gottlieb J
Radiology; 2023 May; 307(4):e221958. PubMed ID: 37070996
[TBL] [Abstract][Full Text] [Related]
19. Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation.
Ennis SL; Olsen N; Tong WWY; Goddard L; Watson N; Weston L; Iqbal A; Patel P; Malouf MA; Plit ML; Darley DR
Am J Transplant; 2023 Jul; 23(7):1009-1021. PubMed ID: 37054889
[TBL] [Abstract][Full Text] [Related]
20. Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction.
Tissot A; Durand E; Goronflot T; Coiffard B; Renaud-Picard B; Roux A; Demant X; Mornex JF; Falque L; Salpin M; Le Pavec J; Villeneuve T; Boussaud V; Knoop C; Magnan A; Lair D; Berthelot L; Danger R; Brouard S;
Respir Res; 2024 Feb; 25(1):88. PubMed ID: 38336710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
